BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8950710)

  • 1. Inherited demyelinating peripheral neuropathies: relating myelin packing abnormalities to P0 molecular defects.
    Kirschner DA; Szumowski K; Gabreëls-Festen AA; Hoogendijk JE; Bolhuis PA
    J Neurosci Res; 1996 Nov; 46(4):502-8. PubMed ID: 8950710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in demyelinating peripheral neuropathies support molecular model of myelin P0-glycoprotein extracellular domain.
    Kirschner DA; Saavedra RA
    J Neurosci Res; 1994 Sep; 39(1):63-9. PubMed ID: 7528817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically distinct codon 69 mutations in major myelin protein zero in demyelinating neuropathies.
    Meijerink PH; Hoogendijk JE; Gabreëls-Festen AA; Zorn I; Veldman H; Baas F; de Visser M; Bolhuis PA
    Ann Neurol; 1996 Oct; 40(4):672-5. PubMed ID: 8871588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination.
    Warner LE; Hilz MJ; Appel SH; Killian JM; Kolodry EH; Karpati G; Carpenter S; Watters GV; Wheeler C; Witt D; Bodell A; Nelis E; Van Broeckhoven C; Lupski JR
    Neuron; 1996 Sep; 17(3):451-60. PubMed ID: 8816708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glimpsing myelin's protein glue.
    Barinaga M
    Science; 1996 Sep; 273(5282):1657-8. PubMed ID: 8830409
    [No Abstract]   [Full Text] [Related]  

  • 6. Charcot-Marie-Tooth disease and related peripheral neuropathies: novel mutations in the peripheral myelin genes connexin 32 (Cx32), peripheral myelin protein 22 (PMP22), and peripheral myelin protein zero (MPZ).
    Ekici AB; Schweitzer D; Park O; Lorek D; Rautenstrauss B; Krüger G; Friedl W; Uhlhaas S; Bathke K; Heuss D; Kayser C; Grehl H
    Neurogenetics; 2000 Sep; 3(1):49-50. PubMed ID: 11085599
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions.
    Hasse B; Bosse F; Hanenberg H; Müller HW
    Mol Cell Neurosci; 2004 Dec; 27(4):370-8. PubMed ID: 15555916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo mutation (Arg98-->Cys) of the myelin P0 gene and uncompaction of the major dense line of the myelin sheath in a severe variant of Charcot-Marie-Tooth disease type 1B.
    Komiyama A; Ohnishi A; Izawa K; Yamamori S; Ohashi H; Hasegawa O
    J Neurol Sci; 1997 Jul; 149(1):103-9. PubMed ID: 9168174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice.
    Previtali SC; Quattrini A; Fasolini M; Panzeri MC; Villa A; Filbin MT; Li W; Chiu SY; Messing A; Wrabetz L; Feltri ML
    J Cell Biol; 2000 Nov; 151(5):1035-46. PubMed ID: 11086005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
    Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
    Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
    Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
    Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease.
    Roa BB; Warner LE; Garcia CA; Russo D; Lovelace R; Chance PF; Lupski JR
    Hum Mutat; 1996; 7(1):36-45. PubMed ID: 8664899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder.
    Rünker AE; Kobsar I; Fink T; Loers G; Tilling T; Putthoff P; Wessig C; Martini R; Schachner M
    J Cell Biol; 2004 May; 165(4):565-73. PubMed ID: 15148307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of large myelin protein zero leads to Charcot-Marie-Tooth disease-like neuropathy in mice.
    Otani Y; Ohno N; Cui J; Yamaguchi Y; Baba H
    Commun Biol; 2020 Mar; 3(1):121. PubMed ID: 32170207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural protein zero expression in Charcot-Marie-Tooth type 1B disease.
    Sindou P; Vallat JM; Chapon F; Archelos JJ; Tabaraud F; Anani T; Braund KG; Maisonobe T; Hauw JJ; Vandenberghe A
    Muscle Nerve; 1999 Jan; 22(1):99-104. PubMed ID: 9883862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A somatic and germline mosaic mutation in MPZ/P(0) mimics recessive inheritance of CMT1B.
    Fabrizi GM; Ferrarini M; Cavallaro T; Jarre L; Polo A; Rizzuto N
    Neurology; 2001 Jul; 57(1):101-5. PubMed ID: 11445635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P0-deficient knockout mice as tools to understand pathomechanisms in Charcot-Marie-Tooth 1B and P0-related Déjérine-Sottas syndrome.
    Martini R
    Ann N Y Acad Sci; 1999 Sep; 883():273-80. PubMed ID: 10586252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic clustering in MPZ mutations.
    Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
    Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the histopathologic, genotypic, and phenotypic features of hereditary peripheral neuropathies in childhood.
    Ouvrier R
    J Child Neurol; 1996 Mar; 11(2):133-46. PubMed ID: 8881991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.